Molnupiravir – what you need to know
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]
A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session […]
Pharmacists and pharmacy technicians are set to benefit from a further investment of up to £15.9m over the next four years. This investment, announced by Health Education England […]
A study of rheumatology patients and clinicians has found that while the majority found phone or video consultations more convenient than face-to-face consultations, they viewed so-called telemedicine as […]
Inviting your MP to spend a day shadowing your work is a good way to raise awareness of the critical work that pharmacists undertake in the healthcare system, […]
In response to Sajid Javid’s statement that he would give pharmacists the right to prescribe to give doctors more time with patients, Jonathan Ashworth immediately tweeted that pharmacists […]
Persons with Type 2 diabetes can, through diet and pharmacist supervision, eliminate the need for diabetes medications, researchers reported on Sept. 10, 2021 in Nature Communications. “There is […]
The key message for primary care is about using the guidance document, Differentiation of the Cs to enable health care professionals to triage patients more accurately, says Professor David Baldwin, […]
Differentiation of the Cs is a document aimed at health care professionals working in primary care to help them to triage their patients. It provides a simple table that […]
The lung cancer service has been very seriously affected by the coronavirus pandemic, in particular, lung cancer referrals have fallen sharply during lockdown, says Professor David Baldwin, chairman […]